Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidade: FM
Subjects: DIABETES MELLITUS, ALBUMINAS (METABOLISMO), MACRÓFAGOS
ABNT
IBORRA, R. T. et al. Selective inhibition of proteasomal and lysosomal degradation pathways partially prevent abca-1 reduction in macrophages induced by advanced glycated albumin. Atherosclerosis. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.sciencedirect.com/science/article/pii/S0021915014004961. Acesso em: 28 set. 2024. , 2014APA
Iborra, R. T., Machado-Lima, A., Okuda, L. S., Machado, J. T., Neves, M. Q., Corrêa-Giannella, M. L., et al. (2014). Selective inhibition of proteasomal and lysosomal degradation pathways partially prevent abca-1 reduction in macrophages induced by advanced glycated albumin. Atherosclerosis. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.sciencedirect.com/science/article/pii/S0021915014004961NLM
Iborra RT, Machado-Lima A, Okuda LS, Machado JT, Neves MQ, Corrêa-Giannella ML, Nakandakare ER, Passarelli M. Selective inhibition of proteasomal and lysosomal degradation pathways partially prevent abca-1 reduction in macrophages induced by advanced glycated albumin [Internet]. Atherosclerosis. 2014 ; 235( 2): e97-e98 res. EAS-0219.[citado 2024 set. 28 ] Available from: http://www.sciencedirect.com/science/article/pii/S0021915014004961Vancouver
Iborra RT, Machado-Lima A, Okuda LS, Machado JT, Neves MQ, Corrêa-Giannella ML, Nakandakare ER, Passarelli M. Selective inhibition of proteasomal and lysosomal degradation pathways partially prevent abca-1 reduction in macrophages induced by advanced glycated albumin [Internet]. Atherosclerosis. 2014 ; 235( 2): e97-e98 res. EAS-0219.[citado 2024 set. 28 ] Available from: http://www.sciencedirect.com/science/article/pii/S0021915014004961